تعداد نشریات | 20 |
تعداد شمارهها | 1,149 |
تعداد مقالات | 10,518 |
تعداد مشاهده مقاله | 45,415,541 |
تعداد دریافت فایل اصل مقاله | 11,291,346 |
Treatment-related Complications in Childhood Acute Lymphoblastic Leukemia: Results of Medical Research Council UKALL X | ||
Middle East Journal of Cancer | ||
مقاله 5، دوره 11، شماره 2 - شماره پیاپی 42، تیر 2020، صفحه 168-173 اصل مقاله (113.43 K) | ||
نوع مقاله: Original Article(s) | ||
شناسه دیجیتال (DOI): 10.30476/mejc.2019.81253.0 | ||
نویسندگان | ||
Ehsan Shahverdi* 1؛ Pedram Karami2؛ Farzaneh Tavakoli3؛ Massoumeh Maki4؛ Meysam Moazzami5؛ Fatemeh Feizi6؛ Peyman Salamati7؛ Alireza Lotfipour7؛ Mohammad Ali Ehsani7 | ||
1Department of Cardiology, Angiology and Sleep Medicine, Bonifatius Hospital Lingen, Lingen, Germany | ||
2Department of Otorhinolaryngology-Head and Neck Surgery, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran | ||
3Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | ||
4Department of Nursing and Midwifery, Falavarjan Branch, Islamic Azad University, Isfahan, Iran | ||
5Department of Pediatrics, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran | ||
6Department of Laboratory Hematology and Blood Bank, School of Allied Medical Sciences, Shahid Beheshi University of Medical Science, Tehran, Iran | ||
7Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran | ||
چکیده | ||
Background: Acute lymphoblastic leukemia (ALL) is a heterogeneous group of lymphoid neoplasms resulting from the proliferation of malignant lymphoid cells. The aim of this study was to evaluate treatment-related complications in children with ALL receiving the Medical Research Council (MRC) UKALL X protocol. Methods: In this retrospective cross-sectional study, children with ALL receiving the MRC UKALL X protocol from 2008 to 2015 in Bahrami University Hospital, Iran, were enrolled. The clinical and morphological features were analysed and treatment-related complications were assessed. Results: Out of 67 children with ALL receiving the MRC UKALL X protocol, 44 (65.6 %) were boys and 23 (34.4%) were girls. Seven patients (10.7%) relapsed in the three years of diagnosis, and 50 children (74.6%) had an overall survival of three years. Average age in three-year-survival group and mortality group was 6.92 (SD: 3.96) and 6.35 (SD: 7.47), respectively (P= 0.38). Conclusion: Overall survival and relapse rates in this study confirm that this protocol is an appropriate treatment strategy. | ||
کلیدواژهها | ||
Acute lymphoblastic leukemia (ALL)؛ Mortality؛ MRC UKALL X؛ Neutropenia؛ Pediatric | ||
آمار تعداد مشاهده مقاله: 3,563 تعداد دریافت فایل اصل مقاله: 2,045 |